← 返回

皮肤鳞状细胞癌的发生与 ILC1 和 NK 细胞随时间浸润并伴随免疫功能失调相关

英文原题:Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions.

查看英文原题

Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions.

PubMed 2021/04/05(内容时间) J Invest Dermatol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

NK细胞和组织驻留固有淋巴细胞(ILC)是皮肤中存在的固有免疫效应细胞。为了研究它们在皮肤鳞状细胞癌(cSCC)发展过程中的时间动态和特定功能,我们结合了小鼠和人类cSCC的转录组学和免疫表型分析。

我们发现了NK细胞和ILC1的浸润以及少量ILC3的存在。在NK细胞和ILC缺陷的Nfil3 -/-小鼠中过继转移NK细胞揭示了NK细胞在cSCC早期控制中的作用。在肿瘤进展过程中,我们发现在乳头状瘤阶段,非典型ILC1浸润分泌炎性细胞因子但IFN-γ水平降低的群体偏移。NK细胞和ILC1功能受损,细胞毒性和IFN-γ分泌减少,与活化受体下调相关。它们在小鼠和人类cSCC中还表现出高度异质性,表达多种耗竭标志物,包括NK细胞上的TIGIT以及ILC1上的PD-1和TIM-3。

我们的数据显示,在癌前阶段炎性ILC1富集,同时NK细胞和ILC1的抗肿瘤功能受损,这可能促进cSCC的发展,因此表明未来的免疫疗法应同时考虑这两种ILC群体。

展开英文摘要原文

NK cells and tissue-resident innate lymphoid cells (ILCs) are innate effectors found in the skin. To investigate their temporal dynamics and specific functions throughout the development of cutaneous squamous cell carcinoma (cSCC), we combined transcriptomic and immunophenotyping analyses in mouse and human cSCCs.

We identified an infiltration of NK cells and ILC1s as well as the presence of a few ILC3s. Adoptive transfer of NK cells in NK cell‒ and ILC-deficient Nfil3 -/- mice revealed a role for NK cells in early control of cSCC. During tumor progression, we identified a population skewing with the infiltration of atypical ILC1 secreting inflammatory cytokines but reduced levels of IFN-γ at the papilloma stage.

NK cells and ILC1s were functionally impaired, with reduced cytotoxicity and IFN-γ secretion associated with the downregulation of activating receptors. They also showed a high degree of heterogeneity in mouse and human cSCCs with the expression of several markers of exhaustion, including TIGIT on NK cells and PD-1 and TIM-3 on ILC1s.

Our data show an enrichment in inflammatory ILC1 at the precancerous stage together with impaired antitumor functions in NK cells and ILC1 that could contribute to the development of cSCC and thus suggest that future immunotherapies should take both ILC populations into account.

论文信息

作者
Luci C、Bihl F、Bourdely P、Khou S、Popa A、Meghraoui-Kheddar A、Vermeulen O、Elaldi R
第一作者单位
Molecular and Cellular Pharmacology Institute, CNRS UMR7275, Côte d'Azur University, Valbonne, France; C3M, INSERM U1065, Côte d'Azur University, Nice, France.Germany
通讯作者单位
Molecular and Cellular Pharmacology Institute, CNRS UMR7275, Côte d'Azur University, Valbonne, France. Electronic address: anjuere@ipmc.cnrs.fr.Germany
文献类型
非美国政府资助研究
期刊
The Journal of investigative dermatology2021 Oct
原文标识
PubMed 33831432 · DOI 10.1016/j.jid.2021.03.018